骨保护素
兰克尔
骨转移
转移
激活剂(遗传学)
癌症研究
秩配基
受体
医学
内科学
癌症
出处
期刊:Chinese Journal of Laboratory Medicine
日期:2019-01-11
卷期号:42 (1): 14-17
标识
DOI:10.3760/cma.j.issn.1009-9158.2019.01.004
摘要
Tumor bone metastasis is one of the main causes of treatment failure in tumor. Since tumor bone metastasis is a complex process, the exact etiopathogenesis of tumor bone metastasis has not been clarified. Recent studies demonstrated that osteoprotegerin/receptor activator of NF-κB ligand/receptor activator of NF-κB (OPG/RANKL/RANK) system plays an important role during the development and progression of tumor bone metastasis. In this review, the research progress of OPG/RANKL/RANK system, including biological functions,the bone microenvironment regulation, the detection method,the diagnosis and treatment of tumor will be summerized.
Key words:
Neoplasm metastasis; Bone neoplasms; Osteoprotegerin; RANK Ligand; Receptor activator of nuclear factor-kappa B
科研通智能强力驱动
Strongly Powered by AbleSci AI